Acute promyelocytic leukaemia
Showing 1 - 25 of >10,000
The Acute Promyelocytic Leukaemia Asian Consortium Project
Recruiting
- Acute Promyelocytic Leukemia
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022
Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)
Recruiting
- Acute Promyelocytic Leukemia
- Oral arsenic Trioxide, ATRA and ascorbic acid
-
Hong Kong, N/A = Not Applicable, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Nov 3, 2020
Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)
Recruiting
- Acute Promyelocytic Leukemia
- Oral Arsenic Trioxide Formulation
-
Hong Kong, Hong KongThe University of Hong Kong
Dec 29, 2020
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Sep 18, 2023
Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)
Recruiting
- Promyelocytic Leukemia
- Arsenic trioxide
- all-trans retinoic acid
-
Monterrey, Nuevo Leon, MexicoHopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022
Acute Promyelocytic Leukaemia Trial (Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid)
Not yet recruiting
- Acute Promyelocytic Leukaemia
- Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
- (no location specified)
Nov 26, 2019
Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)
Recruiting
- Newly-diagnosed APL (de Novo or Therapy-related)
- Relapsed APL
- observational
-
Dresden, GermanyProf. Dr. U. Platzbecker
Aug 10, 2022
Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- SY-2101
- Arsenic Trioxide
-
Birmingham, Alabama
- +4 more
Jul 12, 2022
Acute Leukemia Trial in Hull
Completed
- Acute Leukemia
-
Hull, United KingdomHull University Teaching Hospital NHS Trust
Nov 7, 2022
Immunophenotypic Evaluation of IL-7R a in Acute Leukaemia
Not yet recruiting
- Benefit: To Patient Have Investigation for Diagnosis and Follow up for His Disease and Reach to New Method Help in Early Diagnosis of Lymphoid Disorder
- (no location specified)
Nov 30, 2022
Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)
Active, not recruiting
- Acute Myeloid Leukaemia
- S 64315 (also referred as MIK665) and azacitidine
-
Houston, Texas
- +6 more
Dec 16, 2022
Acute Myeloid Leukaemia Trial in Australia, France, United States (S 64315 (also referred as MIK665) and venetoclax)
Terminated
- Acute Myeloid Leukaemia
- S 64315 (also referred as MIK665) and venetoclax
-
New Haven, Connecticut
- +6 more
Dec 20, 2022
Pregnancy in Acute Promielocitic Leukaemia Patients Treated With
Recruiting
- Acute Promyelocytic Leukemia
- Pregnancy
-
Alessandria, Italy
- +36 more
Dec 31, 2021
Acute Lymphoblastic Leukaemia - Category Trial in Leicester (Ciprofloxacin, Antibiotic)
Recruiting
- Acute Lymphoblastic Leukaemia - Category
-
Leicester, United KingdomLeicester Royal Infirmary
Jul 5, 2022
Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))
Not yet recruiting
- Relapsed Acute Myeloid Leukaemia
- Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
- (no location specified)
Jul 4, 2023
Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU de Nantes
Jan 24, 2023
Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk
Recruiting
- Acute Promyelocytic Leukemia
- Arsenic Trioxide
-
Alessandria, Italy
- +27 more
Dec 31, 2021
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Recruiting
- Promyelocytic Leukemia, Adult Acute
- Evaluation of first line treatment with ATO/ATRA outcome
-
Caba, Argentina
- +1 more
Nov 9, 2021
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)
Recruiting
- Cancer
- +4 more
- INKmune
-
Athens, Attiki, Greece
- +2 more
Jul 3, 2023
Acute B-Cell Lymphoblastic Leukaemia Trial in Brazil (Spectrila®)
Recruiting
- Acute B-Cell Lymphoblastic Leukaemia
-
Belo Horizonte, Brazil
- +7 more
Aug 26, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase
Recruiting
- Lymphoblastic Leukemia
- +4 more
- Phase I
- Phase II
-
Singapore, SingaporeKK Women's and Children's hospital
Jun 20, 2022